1,045
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania

, ORCID Icon, ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 2369-2378 | Published online: 24 Jun 2021

References

  • The World Bank. By 2050, drug-resistant infections could cause global economic damage on par with 2008 financial crisis; 2016. Available from: https://www.worldbank.org/en/news/press-release/2016/09/18/by-2050-drug-resistant-infections-could-cause-global-economic-damage-on-par-with-2008-financial-crisis. Accessed 114, 2021.
  • Gajdács M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics (Basel). 2019;8(3):129. doi:10.3390/antibiotics8030129
  • European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - annual epidemiological report for 2019; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019. Accessed 301, 2021.
  • Gatt YE, Margalit H. Common adaptive strategies underlie within-host evolution of bacterial pathogens. Mol Biol Evol. 2021;38(3):1101–1121. doi:10.1093/molbev/msaa27833118035
  • Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016;2016:2475067. doi:10.1155/2016/247506727274985
  • Tatu AL, Merezeanu N, Pântea O, et al. Resistance features of Pseudomonas aeruginosa strains isolated from patients with infectious complications of cardiovascular surgery. Biointerface Res Appl Chem. 2017;7(2):2004–2008.
  • Sarshar M, Behzadi P, Scribano D, Palamara AT, Ambrosi C. Acinetobacter baumannii: an ancient commensal with weapons of a pathogen. Pathogens. 2021;10(4):387. doi:10.3390/pathogens1004038733804894
  • Senobar Tahaei SA, Stájer A, Barrak I, Ostorházi E, Szabó D, Gajdács M. Correlation between biofilm-formation and the antibiotic resistant phenotype in staphylococcus aureus isolates: a laboratory-based study in Hungary and a review of the literature. Infect Drug Resist. 2021;14:1155–1168. doi:10.2147/IDR.S30399233790586
  • Juhász J, Ligeti B, Gajdács M, et al. Colonization dynamics of multidrug-resistant Klebsiella pneumoniae are dictated by microbiota-cluster group behavior over individual antibiotic susceptibility: a metataxonomic analysis. Antibiotics (Basel). 2021;10(3):268. doi:10.3390/antibiotics1003026833800048
  • Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014;12(10):1221–1236. doi:10.1586/14787210.2014.95609225199988
  • Behzadi P, Baráth Z, Gajdács M. It’s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant pseudomonas aeruginosa. Antibiotics (Basel). 2021;10(1):42. doi:10.3390/antibiotics1001004233406652
  • Gajdács M, Bátori Z, Ábrók M, Lázár A, Burián K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life (Basel). 2020;10(2):16. doi:10.3390/life10020016
  • Gheorghe I, Tatu AL, Lupu I, et al. Molecular characterization of virulence and resistance features in Staphylococcus aureus clinical strains isolated from cutaneous lesions in patients with drug adverse reactions. Rom Biotechnol Lett. 2017;22(1):12321–12327.
  • Tatu AL, Nwabudike LC. Rosacea-like demodicosis (but not primary demodicosis) and papulo pustular rosacea may be two phenotypes of the same disease-a microbioma, therapeutic and diagnostic tools perspective. J Eur Acad Dermatol Venereol. 2019;33(1):e46–e47. doi:10.1111/jdv.1516629959784
  • Pricop R, Cristea VC, Gheorghe I, Tatu AL, Mihaescu G, Chifiriuc MC. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) reveals the anaerobic Slakia exigua as unique etiology of a dental abscess. Biointerface Res Appl Chem. 2017;7(2):1995–1997.
  • Niculet E, Chioncel V, Elisei AM, et al. Multifactorial expression of IL‑6 with update on COVID‑19 and the therapeutic strategies of its blockade (Review). Exp Ther Med. 2021;21:263. doi:10.3892/etm.2021.969333603870
  • Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: the old and the new. Clin Cosmet Investig Dermatol. 2020;13:1041–1050. doi:10.2147/CCID.S224211
  • Niculet E, Radaschin DS, Nastase F, et al. Influence of phytochemicals in induced psoriasis (Review). Exp Ther Med. 2021;20:3421–3424.
  • World Health Organization. Global action plan on antimicrobial resistance, 2015‎. World Health Organization; 2021. Available from: https://www.who.int/antimicrobial-resistance/global-action-plan/en/. Accessed 212, 2021.
  • Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113–1123. doi:10.4065/mcp.2011.035822033257
  • Ashiru-Oredope D, Kerr F, Hughes S, et al. Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom. Antibiotics. 2021;10:110–122. doi:10.3390/antibiotics1002011033498716
  • Spitalului Clinic Județean de Urgență „Pius Brînzeu”, Timișoara. Ordinul MS nr. 1101/2016 privind aprobarea Normelor de supraveghere, prevenire și limitare a infecțiilor asociate asistenței medicale în unitățile sanitare. Monitorul Oficial, Partea I nr. 791 din 07 octombrie 2016 [Romanian; national law – in-hospital medical assistance infection surveillance, preventing and limiting norms]; 2021. Available from: https://www.hosptm.ro/files/juridic/2016/ordinul_nr._1101_din_07.10.2016.pdf. Accessed 215, 2021.
  • Van Dijck C, Vlieghe E, Cox JA. Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review. Bull World Health Organ. 2018;96(4):266–280. doi:10.2471/BLT.17.20344829695883
  • Anikst V, Becket S, Tsan A. Ensuring reliable antimicrobial susceptibility test (AST) results when using an automated AST system. CLSI AST News Update. 2020;5(1):5–8.
  • Leber AL. Clinical Microbiology Procedures Handbook. 4th ed. Washington, DC: ASM Press; 2016.
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI Supplement M100. Wayne PA: Clinical and Laboratory Standards Institute; 2016.
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI Supplement M100. Wayne PA: Clinical and Laboratory Standards Institute; 2017.
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI Supplement M100. Wayne PA: Clinical and Laboratory Standards Institute; 2018.
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI Supplement M100. Wayne PA: Clinical and Laboratory Standards Institute; 2019.
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI Supplement M100. Wayne PA: Clinical and Laboratory Standards Institute; 2020.
  • Sahni RD, Mathai D, Sudarsanam TD, et al. Extended-spectrum beta-lactamase producers: detection for the diagnostic laboratory. J Glob Infect Dis. 2018;10(3):140–146. doi:10.4103/jgid.jgid_49_1730166813
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Kassim A, Omuse G, Premji Z, Revathi G. Comparison of clinical laboratory standards institute and European committee on antimicrobial susceptibility testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study. Ann Clin Microbiol Antimicrob. 2016;15:21. doi:10.1186/s12941-016-0135-327068515
  • Centrul National de Supraveghere si Control al Bolilor Transmisibile. Popescu GA, Șerban R, Niculcea A. CARMIN-ROM 2017 (Consumul de antibiotice, Rezistența microbiană și Infecții asociate asistenței medicale (Nosocomiale) în România - 2017), Institutul Național de Sănătate Publică; 2019. Available from: https://www.cnscbt.ro/index.php/analiza-date-supraveghere/infectii-nosocomiale-1/1309-consumul-de-antibiotice-rezistenta-microbiana-si-infectii-asociate-asistentei-medicale-nosocomiale-in-romania-2017/file. Acessed 15, 2021.
  • Erdem H, Puca E, Ruch Y, et al. Portraying infective endocarditis: results of multinational ID-IRI study. Eur J Clin Microbiol Infect Dis. 2019;38(9):1753–1763. doi:10.1007/s10096-019-03607-x31187307
  • Amin M, Sirous M, Javaherizadeh H, et al. Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran. Infect Drug Resist. 2018;11:1097–1104.30127627
  • Abbasi Montazeri E, Seyed-Mohammadi S, Asarehzadegan Dezfuli A, et al. Investigation of SCCmec types I-IV in clinical isolates of methicillin-resistant coagulase-negative staphylococci in Ahvaz, Southwest Iran. Biosci Rep. 2020;40(5):BSR20200847. doi:10.1042/BSR2020084732347308
  • European Public Health Alliance. In the Red Zone – antimicrobial Resistance: lessons from Romania. Brussels; 2017. Available from: https://epha.org/wp-content/uploads/2017/06/In-the-red-zone-EPHA.pdf. Acessed 215, 2021.
  • World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis; 2017. Available from: https://www.who.int/medicines/areas/rational_use/PPLreport_2017_09_19.pdf?ua=1. Accessed 212, 2021.
  • Rebegea L, Firescu D, Baciu G, Ciubara A. Psycho-Oncology Support. BRAIN. 2019;10(3):77–88.
  • Rebegea LF, Firescu D, Dumitru M, Pătraşcu A. Skin spiradenocarcinoma - case presentation. Rom J Morphol Embryol. 2016;57(1):327–330.27151731
  • Tatu AL, Elisei AM, Chioncel V, Miulescu M, Nwabudike LC. Immunologic adverse reactions of β-blockers and the skin. Exp Ther Med. 2019;18(2):955–959. doi:10.3892/etm.2019.750431384329
  • Draganescu M, Baroiu L, Iancu A, et al. Perspectives on skin disorder diagnosis among people living with HIV in southeastern Romania. Exp Ther Med. 2021;21:97. doi:10.3892/etm.2020.952933363608